Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy

被引:22
|
作者
Minamikawa, Takeo [1 ,2 ,3 ,4 ]
Ichimura-Shimizu, Mayuko [4 ,5 ]
Takanari, Hiroki [4 ,6 ]
Morimoto, Yuki [4 ,5 ]
Shiomi, Ryosuke [2 ]
Tanioka, Hiroki [2 ]
Hase, Eiji [1 ,4 ]
Yasui, Takeshi [1 ,2 ,4 ]
Tsuneyama, Koichi [4 ,5 ,6 ]
机构
[1] Tokushima Univ, Inst PostLED Photon, Dept PostLED Photon Res, 2-1 Minami Josanjima, Tokushima 7708506, Japan
[2] Tokushima Univ, Grad Sch Technol Ind & Social Sci, 2-1 Minami Josanjima, Tokushima 7708506, Japan
[3] Japan Sci & Technol Agcy JST, PRESTO, 2-1 Minami Josanjima, Tokushima, Tokushima 7708506, Japan
[4] Tokushima Univ, Res Cluster Multiscale Vibrat Microscopy Comprehe, 2-1 Minami Josanjima, Tokushima, Tokushima 7708506, Japan
[5] Tokushima Univ, Grad Sch Med Sci, Dept Pathol & Lab Med, 3-18-15 Kuramoto, Tokushima, Tokushima 7708503, Japan
[6] Tokushima Univ, Inst PostLED Photon, Dept Interdisciplinary Res Med & Photon, 3-18-15 Kuramoto, Tokushima, Tokushima 7708503, Japan
基金
日本科学技术振兴机构; 日本学术振兴会;
关键词
NAFLD; FLUORESCENCE; PATHOGENESIS; BODIES; NASH; DIET;
D O I
10.1038/s41598-020-75604-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Predominant evidence of non-alcoholic fatty liver disease (NAFLD) is the accumulation of excess lipids in the liver. A small group with NAFLD may have a more serious condition named non-alcoholic steatohepatitis (NASH). However, there is a lack of investigation of the accumulated lipids with spatial and molecular information. Raman microscopy has the potential to characterise molecular species and structures of lipids based on molecular vibration and can achieve high spatial resolution at the organelle level. In this study, we aim to demonstrate the feasibility of Raman microscopy for the investigation of NAFLD based on the molecular features of accumulated lipids. By applying the Raman microscopy to the liver of the NASH model mice, we succeeded in visualising the distribution of lipid droplets (LDs) in hepatocytes. The detailed analysis of Raman spectra revealed the difference of molecular structural features of the LDs, such as the degree of saturation of lipids in the LDs. We also found that the inhomogeneous distribution of cholesterol in the LDs depending on the histology of lipid accumulation. We visualised and characterised the lipids of NASH model mice by Raman microscopy at organelle level. Our findings demonstrated that the Raman imaging analysis was feasible to characterise the NAFLD in terms of the molecular species and structures of lipids.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [32] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [33] Vitamins and non-alcoholic fatty liver disease: A molecular insight
    Raza, Sana
    Tewari, Archana
    Rajak, Sangam
    Sinha, Rohit A.
    LIVER RESEARCH, 2021, 5 (02) : 62 - 71
  • [34] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [35] Lipid droplets-specific fluorescent probe for wash-free imaging and in vivo diagnosis of non-alcoholic fatty liver disease
    Wang, Yuqing
    Yang, Jing
    Wang, Jie
    Zhang, Sichen
    Tang, Fang
    Chen, Jiexia
    Ding, Aixiang
    Hu, Lei
    Wang, Hui
    MICROCHIMICA ACTA, 2024, 191 (09)
  • [36] Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging
    Gong, Zhenwei
    Tas, Emir
    Yakar, Shoshana
    Muzumdar, Radhika
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 455 (0C) : 115 - 130
  • [37] The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
    Perla, Francesco M.
    Prelati, Maurizia
    Lavorato, Michela
    Visicchio, Daniele
    Anania, Caterina
    CHILDREN-BASEL, 2017, 4 (06):
  • [38] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [39] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [40] SAROGLITAZAR MAGNESIUM IMPROVES LIPID PARAMETERS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE / NON-ALCOHOLIC STEATOHEPATITIS
    Parmar, D.
    Gawrieh, S.
    Cusi, K.
    Chalasani, N.
    Cisneros Garza, L. Esthela
    Bihari, C.
    Cruz Lopez, J. L. Pio
    Bainbridge, J.
    Vellanki, R.
    Shaikh, F.
    Jain, P.
    Maroo, S.
    Manjunath, K.
    Parmar, K.
    Patil, K.
    ATHEROSCLEROSIS, 2020, 315 : E47 - E47